Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Transition metal ions regulated oxygen evolution reaction performance of Ni-based hydroxides hierarchical nanoarrays.

Scientific Reports 2017 April 7
Nickel-based hydroxide hierarchical nanoarrays (Niy M(OH)x HNAs M = Fe or Zn) are doped with non-noble transition metals to create nanostructures and regulate their activities for the oxygen evolution reaction. Catalytic performance in these materials depends on their chemical composition and the presence of nanostructures. These novel hierarchical nanostructures contain small secondary nanosheets that are grown on the primary nanowire arrays, providing a higher surface area and more efficient mass transport for electrochemical reactions. The activities of the Niy M(OH)x HNAs for the oxygen evolution reaction (OER) followed the order of Ni2.2 Fe(OH)x  > Ni(OH)2  > Ni2.1 Zn(OH)x , and these trends are supported by density functional theory (DFT) calculations. The Fe-doped nickel hydroxide hierarchical nanoarrays (Ni2.2 Fe(OH)x HNAs), which had an appropriate elemental composition and hierarchical nanostructures, achieve the lowest onset overpotential of 234 mV and the smallest Tafel slope of 64.3 mV dec-1 . The specific activity, which is normalized to the Brunauer-Emmett-Teller (BET) surface area of the catalyst, of the Ni2.2 Fe(OH)x HNAs is 1.15 mA cm-2 BET at an overpotential of 350 mV. This is ~4-times higher than that of Ni(OH)2 . These values are also superior to those of a commercial IrOx electrocatalyst.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app